Navigation Links
Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz
Date:5/22/2012

FORT MYERS, Fla., May 22, 2012 /PRNewswire-iReach/ -- Gentech Pharmaceutical announced today that Dr. Stan Headley has joined the company as Medical Director for its' PhenTabz and ADDTabz products. Dr. Headley brings over 15 years of experience to the world of Integrative Medicine. He holds a Doctorate of Medicine from Spartan Health Science University with clinical training in family medicine at Creighton University School of Medicine and St. Joseph's Hospital in Omaha, Nebraska.

Dr. Headley has served in various capacities in Natural Health as a clinical family medicine practitioner, Chief Medical Officer, Medical Director, Clinical Operations Manager, Natural Products Researcher, Product Training Educator and advocate as a guest speaker on various radio and television programs on Natural Health forums including International radio programs in Puerto Rico and Barbados.

"Dr. Headley's wealth of experience and industry knowledge has already made him a key addition to the Gentech Pharmaceutical family. We are extremely excited to have him as our Medical Director as we continue to grow. Our current products PhenTabz and ADDtabz and new innovations currently in development, paired with increasing demand from our customers led us to look for a skilled professional who understood the incredible opportunities in the field of designer pharmacological alternatives. We have found that professional in Dr. Stan Headley.", says Derek Vest, CEO.

About Gentech Pharmaceutical
Gentech Pharmaceutical applies the science of perfecting and improving current medications and OTC formulations/chemical structures to produce "designer pharmacological alternatives" without the side effects. This unique ability allows Gentech Pharmaceutical to produce the most therapeutically advanced and safe pharmacological pr
'/>"/>

SOURCE Gentech Pharmaceutical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Golden Globe Awards Adds Gentech Pharmaceutical as New Participating Sponsor
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... HILLS, Calif. , Jan. 14, 2014 The Brandeis Medical ... Los Angeles a premier and affordable laser tattoo removal ... special. Dr. Brandeis, focus is in providing high quality cosmetic services ... all patients. " Southern California has ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... , , , , SAN DIEGO and TOKYO, Dec. ... announced that they have entered into a worldwide agreement to ... non-oncology indications. This partnership includes AC220, Ambit,s lead clinical-stage ... earlier this month in relapsed/refractory acute myeloid leukemia (AML), and ...
... Amnis Corporation, a manufacturer of advanced cell imaging systems, ... Annual J.P. Morgan Healthcare Conference. The Conference will be held ... Francisco. David Basiji, Ph.D., Amnis, President and Chief Executive ... in Room F and will discuss the company,s novel technology, ...
Cached Medicine Technology:Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications 2Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications 3Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications 4Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications 5
(Date:7/10/2014)... felt better prepared to respond to an active shooter ... new study in the journal Prehospital and Disaster ... examine the EMS provider comfort level with respect to ... been neutralized or working with law enforcement personnel during ... School shooting, the Virginia Tech campus shooting, the 2009 ...
(Date:7/10/2014)... as the "Mississippi baby" an infant seemingly cured of ... prolonged remission of HIV infection in The New England ... HIV after more than two years of not taking antiretroviral ... specialist and researchers involved in the case. , ... young child, the medical staff involved in the child,s care, ...
(Date:7/10/2014)... Estonian-born Katerina Alba,s research at the University of Huddersfield ... the most popular emulsion-based food products such as ... is starting to gain an international profile for her ... and food science at the University and now she ... with her supervisor, Dr Vassilis Kontogiorgos, she is investigating ...
(Date:7/10/2014)... were more likely to be diagnosed with more ... survived for shorter times than prostate cancer patients ... found. , The negative outcomes may be the ... the mentally ill, depression,s impact on biological cancer ... his general health and disinterest in receiving more ...
(Date:7/9/2014)... WASHINGTON, DC (July 10, 2014) If you think winning ... fun for kids think again: Winning along with other mental ... each of which falls into one of 11 big fun ... that winning is all important when it comes to the ... identify and quantify what goes into this elusive conceptuntil now. ...
Breaking Medicine News(10 mins):Health News:Active shooter training increases comfort level of emergency responders 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:World interest in research work on the benefits of the Okra plant 2Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 3
... Crazy While They Work...30,000+ Dentists Converge in Chicago February ... issued by the Chicago Dental Society:Who: The Chicago ... to find out some wacky, unusual, and just plain ... chair.As we countdown to CDS,s annual Midwinter Meeting, one ...
... to new dental techniques, , , TUESDAY, Feb. 24 (HealthDay ... immune function and the development of skin and the ... Oregon State University researchers have found. , Their discovery ... to new methods of repairing damaged enamel and preventing ...
... music doesn,t necessary cause promiscuity, experts stress, , , ... proof that raunchy music makes kids have sex, but a ... kind of link between "degrading" songs and teenage sexual activity. ... to certain messages in music are more likely to copy ...
... uses search engine optimization and individualized marketing to offer ... 24 Creative Marketing Solutions, LLC (CMS) today announced ... cost-effective way for veterinary practices to market themselves online, ... Much more than just a listing service, My Hometown ...
... Make Them Effective , ... St. Louis, MO (PRWEB) February 24, 2009 ... or some would say failing - health care system at further risk. ... rising. Also, faced with tighter budgets and escalating health care costs, even ...
... 24 With President Obama preparing to,present his budget ... on,his economic stimulus initiatives and a renewed call for ... released new data,on how the most comprehensive healthcare fix ... national economy. , Overall, expanding ...
Cached Medicine News:Health News:Top 5 Most Annoying Dental Patient Behaviors 2Health News:Scientists Find Gene for Tooth Enamel 2Health News:'Degrading' Lyrics Linked to Teen Sex 2Health News:'Degrading' Lyrics Linked to Teen Sex 3Health News:Creative Marketing Solutions Launches My Hometown Vet, Giving Veterinary Practices Better Visibility Online 2Health News:Creative Marketing Solutions Launches My Hometown Vet, Giving Veterinary Practices Better Visibility Online 3Health News:Health and Wellness Programs in a Tight Economy 2
1% tryptone, 0.5% yeast extract, 1.0% Sodium Chloride. 1.5% agararose...
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
... flowing powder. pH: pH(4.7%, H 2 O): ... Yeast Extract: 47% Potassium Phosphate Dibasic: 25% Potassium ... 47 gm powder per liter of purified water. ... and recombinant proteins than LB media by allowing ...
1.2% Tryptone, 2.4% Yeast Extract, 0.4% Glycerol, with 100ml of 10x Phosphate buffer supplement (0190-01)....
Medicine Products: